Related references
Note: Only part of the references are listed.Cystine-glutamate antiporterxCTas a therapeutic target for cancer
Lin Liu et al.
CELL BIOCHEMISTRY AND FUNCTION (2021)
System Xc- Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine
M. Nehser et al.
NEUROCHEMICAL RESEARCH (2020)
Inhibition of type 4 cAMP-phosphodiesterases (PDE4s) in mice induces hypothermia via effects on behavioral and central autonomous thermoregulation
Will McDonough et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Slc7a11 (xCT) protein expression is not altered in the depressed brain and system xc- deficiency does not affect depression-associated behaviour in the corticosterone mouse model
Thomas Demuyser et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Blockade of ALK4/5 signaling suppresses cadmium- and erastin-induced cell death in renal proximal tubular epithelial cells via distinct signaling mechanisms
Kota Fujiki et al.
CELL DEATH AND DIFFERENTIATION (2019)
Novel analogs of sulfasalazine as system xc- antiporter inhibitors: Insights from the molecular modeling studies
Dhavalkumar Patel et al.
DRUG DEVELOPMENT RESEARCH (2019)
Anticonvulsant and antiepileptogenic effects of system xc- inactivation in chronic epilepsy models
Karine Leclercq et al.
EPILEPSIA (2019)
Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells
Mengyu Yu et al.
CANCER SCIENCE (2019)
The possible ameliorative effect of simvastatin versus sulfasalazine on acetic acid induced ulcerative colitis in adult rats
N. A. Soliman et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Improving the practicality of using non-aversive handling methods to reduce background stress and anxiety in laboratory mice
Kelly Gouveia et al.
SCIENTIFIC REPORTS (2019)
Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome
Joanna Bouchat et al.
GLIA (2018)
High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine
Fumitaka Wada et al.
CANCER SCIENCE (2018)
Genetic deletion of xCT attenuates peripheral and central inflammation and mitigates LPS-induced sickness and depressive-like behavior in mice
Giulia Albertini et al.
GLIA (2018)
Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications
Jordi Olloquequi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer
Pranavi Koppula et al.
CANCER COMMUNICATIONS (2018)
Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)
Kohei Shitara et al.
GASTRIC CANCER (2017)
Comparative Evaluation between Sulfasalazine Alone and in Combination with Herbal Medicine on DSS-Induced Ulcerative Colitis Mice
Mi-Rae Shin et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool
Marc Dahlmanns et al.
CELL DEATH DISCOVERY (2017)
Cystine/Glutamate Antiporter Blockage Induces Myelin Degeneration
Federico N. Soria et al.
GLIA (2016)
Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
Ming-zhe Ma et al.
CANCER LETTERS (2015)
Inhibition of System Xc- Transporter Attenuates Autoimmune Inflammatory Demyelination
Kirsten S. Evonuk et al.
JOURNAL OF IMMUNOLOGY (2015)
Main path and byways: non-vesicular glutamate release by system xc- as an important modifier of glutamatergic neurotransmission
Ann Massie et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Absence of system xc- in mice decreases anxiety and depressive-like behavior without affecting sensorimotor function or spatial vision
Eduard Bentea et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice
Pinar Mesci et al.
BRAIN (2015)
Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma
Lu Dai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma
Satoru Takeuchi et al.
NEUROLOGY INDIA (2014)
Behavioral assessment of acute inhibition of system xc - in rats
Victoria Lutgen et al.
PSYCHOPHARMACOLOGY (2014)
The Cystine/Glutamate Antiporter System xc- in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities
Jan Lewerenz et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
Ankita Mehta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effects of Chronic Restraint Stress on Body Weight, Food Intake, and Hypothalamic Gene Expressions in Mice
Joo Yeon Jeong et al.
ENDOCRINOLOGY AND METABOLISM (2013)
Pathology of Demyelinating Diseases
Bogdan F. Gh. Popescu et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Sulfasalazine for brain cancer fits
Harald Sontheimer et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Weijie Guo et al.
CANCER LETTERS (2011)
Pharmacologic Evaluation of Sulfasalazine, FTY720, and Anti-IL-12/23p40 in a TNBS-Induced Crohn's Disease Model
Zaher A. Radi et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Dopaminergic neurons of system xc--deficient mice are highly protected against 6-hydroxydopamine-induced toxicity
Ann Massie et al.
FASEB JOURNAL (2011)
Side effects of control treatment can conceal experimental data when studying stress responses to injection and psychological stress in mice
Solveig Drude et al.
LAB ANIMAL (2011)
Suppression of experimental autoimmune encephalomyelitis by sulfasalazine
M. Prosiegel et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer
P. W. Gout et al.
Current Oncology (2010)
Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults
Pierre A. Robe et al.
BMC CANCER (2009)
Effects of Acute and Chronic Stressors and CRF in Rat and Mouse Tests for Depression
Adrian J. Dunn et al.
STRESS, NEUROTRANSMITTERS, AND HORMONES: NEUROENDOCRINE AND GENETIC MECHANISMS (2008)
The xc- cystine/glutamate antiporter:: A potential target for therapy of cancer and other diseases
Maisie Lo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes
Maria Domercq et al.
JOURNAL OF IMMUNOLOGY (2007)
Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy
Daniel W. Doxsee et al.
PROSTATE (2007)
A hitchhiker's guide to behavioral analysis in laboratory rodents
N Sousa et al.
GENES BRAIN AND BEHAVIOR (2006)
Underlying mechanism for NMDA receptor antagonism by the anti-inflammatory drug, sulfasalazine, in mouse cortical neurons
JH Noh et al.
NEUROPHARMACOLOGY (2006)
Redox imbalance in cystine/glutamate transporter-deficient mice
H Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells
S Chintala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice
JF Cryan et al.
MOLECULAR PSYCHIATRY (2004)
The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors
BR Ryu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Weight loss in rats exposed to repeated acute restraint stress is independent of energy or leptin status
RBS Harris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc- cystine transporter:: a new action for an old drug
PW Gout et al.
LEUKEMIA (2001)
Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
CK Weber et al.
GASTROENTEROLOGY (2000)
Share Paper
